Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
SAI Life Sciences Ltd. ( (IN:SAILIFE) ) has shared an update.
Sai Life Sciences has allotted 244,281 fully paid-up equity shares with a face value of Re 1 each under its Employees Stock Option Plan 2008 and Management ESOP Plan 2018, following board approval on 23 April 2026. The issuance, executed at exercise prices of Rs 188.90 and Rs 127.30 per share respectively, modestly increases the company’s equity base and reflects continued use of stock-based incentives to align employees and management with shareholder interests.
More about SAI Life Sciences Ltd.
Sai Life Sciences Ltd. is an India-based life sciences company listed on BSE and NSE, operating in the pharmaceuticals and biotechnology ecosystem. It provides research, development and related services from its facilities in Hyderabad, with an equity structure that supports employee participation through share-based compensation schemes.
Average Trading Volume: 37,134
Technical Sentiment Signal: Strong Buy
Current Market Cap: 202.9B INR
See more data about SAILIFE stock on TipRanks’ Stock Analysis page.